170 related articles for article (PubMed ID: 21079627)
1. Ten years of the Global Alliance for Vaccines and Immunization: challenges and progress.
Clemens J; Holmgren J; Kaufmann SH; Mantovani A
Nat Immunol; 2010 Dec; 11(12):1069-72. PubMed ID: 21079627
[TBL] [Abstract][Full Text] [Related]
2. The GAVI Financing Task Force: one model of partner collaboration.
Milstien JB; Kamara L; Lydon P; Mitchell V; Landry S
Vaccine; 2008 Dec; 26(51):6699-705. PubMed ID: 19306508
[TBL] [Abstract][Full Text] [Related]
3. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
[TBL] [Abstract][Full Text] [Related]
4. World Health Organization perspectives on the contribution of the Global Alliance for Vaccines and Immunization on reducing child mortality.
Bustreo F; Okwo-Bele JM; Kamara L
Arch Dis Child; 2015 Feb; 100 Suppl 1():S34-7. PubMed ID: 25613965
[TBL] [Abstract][Full Text] [Related]
5. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
[TBL] [Abstract][Full Text] [Related]
6. The Global Alliance for Vaccines and Immunization: is it a new model for effective public-private cooperation in international public health?
Muraskin W
Am J Public Health; 2004 Nov; 94(11):1922-5. PubMed ID: 15514228
[TBL] [Abstract][Full Text] [Related]
7. Perceptions of the usefulness of external support to immunization coverage in Chad: an analysis of the GAVI-Alliance cash-based support.
Ferrinho P; Dramé M; Tumusiime P
Pan Afr Med J; 2013; 15():44. PubMed ID: 24106572
[TBL] [Abstract][Full Text] [Related]
8. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
[TBL] [Abstract][Full Text] [Related]
9. New tendencies and strategies in international immunisation: GAVI and The Vaccine Fund.
Martin JF; Marshall J
Vaccine; 2003 Jan; 21(7-8):587-92. PubMed ID: 12531322
[TBL] [Abstract][Full Text] [Related]
10. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
[TBL] [Abstract][Full Text] [Related]
11. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the GAVI Alliance to improving health and reducing poverty.
Lob-Levyt J
Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2743-7. PubMed ID: 21893535
[TBL] [Abstract][Full Text] [Related]
13. The GAVI Alliance and the 'Gates approach' to health system strengthening.
Storeng KT
Glob Public Health; 2014; 9(8):865-79. PubMed ID: 25156323
[TBL] [Abstract][Full Text] [Related]
14. Country-level governance of global health initiatives: an evaluation of immunization coordination mechanisms in five countries of Asia.
Grundy J
Health Policy Plan; 2010 May; 25(3):186-96. PubMed ID: 19926659
[TBL] [Abstract][Full Text] [Related]
15. Postneonatal mortality impacts following grants from the Gavi Vaccine Alliance: an econometric analysis from 2000 to 2014.
Kolesar RJ; Audibert M
Public Health; 2017 Dec; 153():163-171. PubMed ID: 29102832
[TBL] [Abstract][Full Text] [Related]
16. Challenges to sustainable immunization systems in Gavi transitioning countries.
Cernuschi T; Gaglione S; Bozzani F
Vaccine; 2018 Oct; 36(45):6858-6866. PubMed ID: 30268735
[TBL] [Abstract][Full Text] [Related]
17. How should GAVI build on its success?
Arie S
BMJ; 2011 Sep; 343():d5182. PubMed ID: 21903688
[No Abstract] [Full Text] [Related]
18. Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.
Haakenstad A; Birger M; Singh L; Liu P; Lim S; Ng M; Dieleman JL
Health Aff (Millwood); 2016 Feb; 35(2):242-9. PubMed ID: 26858376
[TBL] [Abstract][Full Text] [Related]
19. Financial challenges of immunization: a look at GAVI.
Kaddar M; Lydon P; Levine R
Bull World Health Organ; 2004 Sep; 82(9):697-702. PubMed ID: 15628208
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation on impact of hepatitis B vaccine integrated into routine immunization in the areas of Ministry of Health/Global Alliance for Vaccine and Immunization (GAVI) Cooperation Project P.R. China].
Cui FQ; Gong XH; Chen YS
Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):289-93. PubMed ID: 20077723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
